Experience

Tai-Yu chemical and pharmaceutical Co., Ltd

• 1 - 100 Employee

• Senior Formulation Scientist

  • Sep 2018 - Present

  → Led formulation experiments for diverse projects involving parenteral dosage forms, immediate and sustained release OSD. → Managed scale-up and exhibit batches to ensure seamless transitions and successful implementation of new formulations. → Designed and monitored QbD batches, gaining insights into critical material quality attributes and process parameters. → Conducted comprehensive experiments using DoE methodology, performed thorough data analysis, and interpreted results to optimize formulation compositions and manufacturing processes. → Prepared and contributed to the development of Tech. Transfer documents, facilitating smooth knowledge transfer across production sites. → Prepared supporting documents for regulatory activities, including ACTD dossier preparation, ensuring compliance with industry regulations and guidelines. → Dissolution profiling and formulation optimization for effective pharmaceutical development → Experienced in analyzing and assessing IPR and patent claims, particularly in the context of Paragraph III and IV generic development Show less



Tai Yu Chemical & Pharmaceutical Co., Ltd

• 1 - 100 Employee

• Associate Researcher

  • Nov 2015 - Aug 2017

  → Conducted comprehensive literature searches, focusing on RLD and relevant patents, to gain valuable insights for informed product development strategies. → Contributed to preformulation studies for various dosage forms, gaining valuable insights into formulation development. → Led the formulation development of enteric-coated tablets, overseeing the process from prototype formulation to scale-up batches at the R&D lab. → Developed and validated analytical methods to ensure accurate and reliable analysis of pharmaceutical products. → Evaluated impurity profiles of finished dosage forms, ensuring compliance with quality standards. → Designed and planned stability studies in accordance with ICH guidelines to assess product shelf life and efficacy. Show less



Delhi University

• E-Learning Providers
• 1 - 100 Employee

• Graduate Research Assistant

  • Jan 2006 - Jun 2006

  Evaluation of BAL Fluid CD4+/CD8+ Lympocytes Subset Ratio in the Patients of Moderate Bronchial Asthma Evaluation of BAL Fluid CD4+/CD8+ Lympocytes Subset Ratio in the Patients of Moderate Bronchial Asthma


National Institute of Rural Development and Panchayati Raj
• India
• Higher Education
• 1 - 100 Employee
• Swarnajayanti Gram Swarojgar Yojana (SGSY), Field Data Collector

  • Nov 2005 - Dec 2005